ERBB2 and Obesity: In our study, analysis of the different subgroups of breast cancer revealed no significant impact of obesity on outcomes in the luminal A-like, luminal B-like and HER2-positive subtypes, but significantly poorer DFS and OS in severely obese compared with underweight/normal weight patients with triple-negative breast cancer.